Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network. Naccache JM, et al. Among authors: bourdin a. Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7. Lancet Respir Med. 2022. PMID: 34506761 Clinical Trial.
Pulmonary hypertension associated with benfluorex exposure.
Savale L, Chaumais MC, Cottin V, Bergot E, Frachon I, Prevot G, Pison C, Dromer C, Poubeau P, Lamblin N, Habib G, Reynaud-Gaubert M, Bourdin A, Sanchez O, Tubert-Bitter P, Jaïs X, Montani D, Sitbon O, Simonneau G, Humbert M. Savale L, et al. Among authors: bourdin a. Eur Respir J. 2012 Nov;40(5):1164-72. doi: 10.1183/09031936.00188611. Epub 2012 Apr 20. Eur Respir J. 2012. PMID: 22523367 Free article.
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
Cadranel J, Philippe B, Hennequin C, Bergeron A, Bergot E, Bourdin A, Cottin V, Jeanfaivre T, Godet C, Pineau M, Germaud P. Cadranel J, et al. Among authors: bourdin a. Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3231-9. doi: 10.1007/s10096-012-1690-y. Epub 2012 Jul 11. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22782438 Free PMC article. Clinical Trial.
Small airways diseases, excluding asthma and COPD: an overview.
Burgel PR, Bergeron A, de Blic J, Bonniaud P, Bourdin A, Chanez P, Chinet T, Dalphin JC, Devillier P, Deschildre A, Didier A, Kambouchner M, Knoop C, Laurent F, Nunes H, Perez T, Roche N, Tillie-Leblond I, Dusser D. Burgel PR, et al. Among authors: bourdin a. Eur Respir Rev. 2013 Jun 1;22(128):131-47. doi: 10.1183/09059180.00001313. Eur Respir Rev. 2013. PMID: 23728867 Free PMC article.
Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.
Bergot E, Sitbon O, Cottin V, Prévot G, Canuet M, Bourdin A, de Groote P, Rottat L, Gressin V, Jaïs X, Humbert M, Simonneau G. Bergot E, et al. Among authors: bourdin a. Int J Cardiol. 2014 Apr 1;172(3):561-7. doi: 10.1016/j.ijcard.2013.12.313. Epub 2014 Jan 22. Int J Cardiol. 2014. PMID: 24529947
Prognostic value of cluster analysis of severe asthma phenotypes.
Bourdin A, Molinari N, Vachier I, Varrin M, Marin G, Gamez AS, Paganin F, Chanez P. Bourdin A, et al. J Allergy Clin Immunol. 2014 Nov;134(5):1043-50. doi: 10.1016/j.jaci.2014.04.038. Epub 2014 Jun 27. J Allergy Clin Immunol. 2014. PMID: 24985405 Clinical Trial.
We should prohibit warfarin in idiopathic pulmonary fibrosis.
Alagha K, Secq V, Pahus L, Sofalvi T, Palot A, Bourdin A, Chanez P. Alagha K, et al. Among authors: bourdin a. Am J Respir Crit Care Med. 2015 Apr 15;191(8):958-60. doi: 10.1164/rccm.201412-2281LE. Am J Respir Crit Care Med. 2015. PMID: 25876206 No abstract available.
Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.
Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group. Deslée G, et al. Among authors: bourdin a. JAMA. 2016 Jan 12;315(2):175-84. doi: 10.1001/jama.2015.17821. JAMA. 2016. PMID: 26757466 Free article. Clinical Trial.
Future treatment for asthma.
Charriot J, Vachier I, Halimi L, Gamez AS, Boissin C, Salama M, Cucu-Jarjour A, Ahmed E, Bourdin A. Charriot J, et al. Among authors: bourdin a. Eur Respir Rev. 2016 Mar;25(139):77-92. doi: 10.1183/16000617.0069-2015. Eur Respir Rev. 2016. PMID: 26929425 Free PMC article.
396 results